logo

For the Inventor, By the Inventor

Laval, Canada

Gilles Sauvé

This inventor holds 11 USPTO granted patents. Top assignee: Pharmacor Inc.. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilles Sauvé. Retrieved from https://idiyas.com/inventor/gilles-sauvandeacute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11

% Patents Active = 81.8

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 79(Granted Patents)


Company Filing History:

goldMedal11 out of 12 
 
Pharmacor Inc.
 patents

Years Active: 2001-2004

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6677367 - HIV protease inhibitors based on amino acid derivatives (2004-01-13),
2. 6656965 - HIV protease inhibitors based on amino acid derivatives (2003-12-02),
3. 6638921 - Pyridoxal-5-phosphate derivatives as HIV integrase inhibitors (2003-10-28),
4. 6610689 - HIV protease inhibitors based on amino acid derivatives (2003-08-26),
5. 6608100 - HIV protease inhibitors based on amino acid derivatives (2003-08-19),
6. 6528655 - Aromatic derivatives with HIV integrase inhibitory properties (2003-03-04),
7. 6528532 - Urea derivatives as HIV aspartyl protease inhibitors (2003-03-04),
8. 6506786 - HIV protease inhibitors based on amino acid derivatives (2003-01-14),
9. 6455587 - Amino acid derivatives as HIV aspartyl protease inhibitors (2002-09-24),
10. 6362165 - Hydroxyphenyl derivatives with HIV integrase inhibitory properties (2002-03-26),
11. 6313177 - D-mannitol derivatives as HIV aspartyl protease inhibitors (2001-11-06),

Title: The Innovations of Gilles Sauvé

Introduction

Gilles Sauvé is a prominent inventor based in Laval, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. With a total of 11 patents to his name, Sauvé's work has had a considerable impact on medical research and treatment options.

Latest Patents

One of his latest patents focuses on HIV protease inhibitors based on amino acid derivatives. This innovative approach aims to enhance the efficacy of treatments for individuals living with HIV. His research continues to push the boundaries of what is possible in the fight against this virus.

Career Highlights

Gilles Sauvé has built a successful career at Pharmacor Inc., where he has been instrumental in advancing research and development initiatives. His expertise in the field has led to numerous breakthroughs that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Sauvé has collaborated with talented individuals such as Jocelyn Yelle and Brent Richard Stranix. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Gilles Sauvé's contributions to the field of pharmaceuticals, particularly in the area of HIV treatment, highlight his dedication to improving healthcare. His innovative spirit and collaborative efforts continue to inspire advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…